Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Study
NCT02581176
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
300
Enrollment
OTHER
Sponsor class
Conditions
Neoplasms
Venous Thrombosis
Interventions
DRUG:
Apixaban
Sponsor
University Hospital, Akershus